FEATURE ARTICLE
Benzylidenes from Carbenes
3793
HRMS (ESI): m/z [M + H]+ calcd for C26H34N3O2: 420.2651; found:
420.265 (error: 0.003).
1,3-Bis(2,6-diisopropylphenyl)-2-(prop-2-enylidene)-2,3-dihy-
dro-1H-imidazole (5)
In a dry box, 1,3-bis(2,6-diisopropylphenyl)imidazolin-2-ylidene23
(2.00 g, 5.15 mmol) was dissolved in THF (60 mL). Freshly dis-
tilled allyl chloride (0.21 mL, 2.6 mmol) was added to the yellow
soln. The mixture was stirred at r.t. for 20 h. After filtration over
Celite, the solvent was removed yielding an orange solid that con-
tained the product, but was contaminated with starting material
(carbene). The ratio of product and carbene was determined by 1H
NMR; corrected yield of 5: 2.29 mmol (89%).
(E)-1-(2,6-Diisopropylphenyl)-3-methyl-2-(4-methylben-
zylidene)-2,3-dihydro-1H-imidazole (4g)
In a dry box, 1-(2,6-diisopropylphenyl)-3-methylimidazolium
iodide26 (9.15 mg, 24.7 mmol) and KOt-Bu (5.84 mg, 51.9 mmol)
were placed in a septum-capped vial. Under an inert atmosphere
THF-d8 (0.6 mL) was added. After ultrasonification the slightly yel-
low soln was transferred into a rubber septum-capped inert NMR
tube. 4-Methylbenzyl bromide (4.57 mg, 24.7 mmol) dissolved in
THF-d8 (0.2 mL) was added. Conversion: 60%.
1H NMR (500 MHz, benzene-d6): d = 7.34 (‘t’, 3JHH = 7.6 Hz, 2 H,
3
H9, H9¢), 7.24 (‘t’, JHH = 7.3 Hz, 4 H, H8, H10, H8¢, H10¢), 5.95
1H NMR (600 MHz, THF-d8): d = 7.32 (t, 3JHH = 7.8 Hz, 1 H, H9),
7.23 (d, 3JHH = 7.8 Hz, 2 H, H8), 6.76 (d, 3JHH = 7.8 Hz, 2 H, H17),
6.65 (d, 3JHH = 7.8 Hz, 2 H, H16), 6.32 (d, 3JHH = 1.9 Hz, 1 H, H4),
6.27 (d, 3JHH = 1.9 Hz, 1 H, H5), 3.75 (s, 1 H, H14), 3.02 (s, 3 H,
H13), 2.91 (sept, 3JHH = 6.9 Hz, 2 H, H10), 2.14 (s, 3 H, H19), 1.17
(d, 3JHH = 2.5 Hz, 1 H, H4 or H5), 5.91 (d, 3JHH = 2.5 Hz, 1 H, H4
3
or H5), 5.89–5.82 (m, 1 H, H19), 4.42 (dd, JHH = 16.1 Hz,
2JHH = 2.6 Hz, 1 H, H20cis), 4.25 (d, 3JHH = 11.8 Hz, 1 H, H18), 4.08
3
2
(dd, JHH = 10.1 Hz, JHH = 2.6 Hz, 1 H, H20trans), 3.45 (sept,
3JHH = 6.9 Hz, 2 H, H12, H15), 3.32 (sept, 3JHH = 6.9 Hz, 2 H, H12¢,
3
3
(d, JHH = 6.9 Hz, 6 H, H12), 1.14–1.12 (d, 6 H, H11; signal ob-
H15¢), 1.49 (d, JHH = 6.9 Hz,
6
H, H14, H17), 1.44 (d,
scured by t-BuOH resonance; coupling constant not determined).
3JHH = 6.9 Hz, 6 H, H14¢, H17¢), 1.32 (d, 3JHH = 6.9 Hz, 6 H, H13,
H16 or H13¢, H16¢), 1.30 (d, 3JHH = 6.9 Hz, 6 H, H13, H16 or H13¢,
H16¢).
13C-APT-NMR (151 MHz, THF-d8): d = 150.3 (d, 1 C, C2), 149.2
(d, 2 C, C7), 138.9 (d, 1 C, C15), 135.3 (d, 1 C, C6), 129.8 (u, 1 C,
C9), 128.7 (u, 2 C, C17), 128.3 (d, 1 C, C18), 125.8 (u, 2 C, C16),
125.0 (u, 2 C, C8), 117.9 (u, 1 C, C4), 117.1 (u, 1 C, C5), 66.9 (u, 1
C, C14), 37.5 (u, 1 C, C13), 29.1 (u, 2 C, C10), 24.6 (u, 2 C, C11),
23.9 (u, 2 C, C12), 21.0 (u, 1 C, C19).
1H NMR (600 MHz, THF-d8): d = 7.39–7.35 (m, 2 H, H9, H9¢),
7.27–7.24 (m, 4 H, H8, H10, H8¢, H10¢), 6.35 (s, 1 H, H4), 6.30 (s,
1 H, H5), 5.29 (m, 1 H, H19), 3.78 (d, 3JHH = 16.0 Hz, 1 H, H20cis),
3
3
3.67 (d, JHH = 11.8 Hz, 1 H, H18), 3.38 (d, JHH = 9.9 Hz, 1 H,
3
H20trans), 3.21 (sept, JHH = 6.9 Hz, 2 H, H12, H15), 3.09 (sept,
1-Ethyl-3-methyl-2-(4-nitrobenzylidene)-2,3-dihydro-1H-imi-
dazole (4i)
3JHH = 6.9 Hz, 2 H, H12¢, H15¢), 1.29–1.16 [m, 24 H, CH(CH3)2].
13C{1H}-NMR (126 MHz, benzene-d6): d = 148.7 (2 C, C7¢, C11¢),
148.1 (2 C, C7, C11), 145.8 (1 C, C2), 136.2 (1 C, C6), 134.0 (1 C,
C6¢), 131.9 (1 C, C19), 129.7 (2 C, C9, C9¢), 124.7 (2 C, C8¢, C10¢),
124.5 (2 C, C8, C10), 116.7 (1 C, C4 or C5), 115.3 (1 C, C4 or C5),
96.9 (1 C, C20), 72.3 (1 C, C18), 29.0 (2 C, C12, C15), 28.8 (2 C,
C12¢, C15¢), 24.2 (4 C, C13, C16, C13¢, C16¢), 23.8 (2 C, C14¢,
C17¢), 23.3 (2 C, C14, C17).
13C NMR (151 MHz, THF-d8): d = 149.2 (d, 2 C, C7¢, C11¢), 148.7
(d, 2 C, C7, C11), 146.5 (d, 1 C, C2), 136.9 (d, 1 C, C6), 134.7 (d,
1 C, C6¢), 132.7 (u, 1 C, C19), 130.0 (u, 2 C, C9, C9¢), 125.0 (u, 2
C, C8 and C10 or C8¢ and C10¢), 124.8 (u, 2 C, C8 and C10 or C8¢
and C10¢), 117.6 (u, 1 C, C5), 116.2 (u, 1 C, C4), 95.1 (d, 1 C, C20),
72.2 (u, 1 C, C18), 29.5 (u, 2 C, C12, C15), 29.4 (u, 2 C, C12¢,
C15¢), 24.3 [u, 2 C, CH(CH3)2], 23.9 [u, 2 C, CH(CH3)2], 23.7 [u, 2
C, CH(CH3)2], 23.4 [u, 2 C, CH(CH3)2].
Under inert conditions, KOt-Bu (62 mg, 0.55 mmol) dissolved in
THF (3 mL) was added to 1-ethyl-3-methylimidazolium bromide
(104.7 mg, 0.548 mmol). After ultrasonification, 4-nitrobenzyl bro-
mide (59.8 mg, 0.277 mmol) dissolved in THF (3 mL) was added to
the colorless turbid carbene soln. Thereupon this turned deep pur-
ple. After stirring over night at r.t. the mixture was filtered through
Celite under argon followed by washing with THF (4 mL). The sol-
vent was removed from the filtrate to give 4i (0.245 mmol, 89%) as
a dark purple glittery solid. The product was highly sensitive to air.
Exposure resulted in immediate color change to black.
3
1H NMR (600 MHz, THF-d8): d = 7.68 (d, JHH = 9.2 Hz, 2 H,
H12), 6.95 (d, 3JHH = 2.3 Hz, 1 H, H5), 6.92 (d, 3JHH = 2.2 Hz, 1 H,
H4), 6.31 (d, 3JHH = 9.2 Hz, 2 H, H11), 4.52 (s, 1 H, H9), 3.79 (q,
3JHH = 7.2 Hz, 2 H, H6), 3.36 (s, 3 H, H8), 1.29 (t, 3JHH = 7.2 Hz, 3
H, H7).
MS (ESI): m/z (%) = 429 (100) [M + H]+, 403 (46), 389 (100).
13C-APT-NMR (151 MHz, THF-d8): d = 150.3 (d, 1 C, C2), 149.8
(d, 1 C, C10), 134.9 (d, 1 C, C13), 125.7 (u, 2 C, C12), 120.0 (u, 1
C, C4), 118.7 (u, 2 C, C11), 117.7 (u, 1 C, C5), 69.0 (u, 1 C, C9),
43.4 (d, 1 C, C6), 35.9 (u, 1 C, C8), 14.5 (u, 1 C, C7).
[1,3-Bis(2,6-diisopropylphenyl)-2,3-dihydro-1H-imidazol-2-
ylidene]acetonitrile (6)
Under inert conditions, 1,3-bis(2,6-diisopropylphenyl)imidazolium
chloride23 (2.00 g, 4.71 mmol) was reacted with KOt-Bu (530 mg,
4.72 mmol) dissolved in THF (15 mL). The orange, turbid mixture
was ultrasonificated followed by stirring at r.t. for 1.5 h. Chloro-
acetonitrile (149 mL, 2.36 mmol) was added. After stirring at r.t. for
3 d the mixture was filtered through Celite under argon. The solvent
was removed from the filtrate. The resulting orange solid was dis-
solved in benzene (15 mL) and filtered again. The red filtrate was
concentrated and colorless crystals of 6 formed (2.31 mmol, 98%);
mp 208 °C.
2-(4-Bromobenzyl)-1,3-di-tert-butylimidazolium Bromide (3k)
In a dry box, 1,3-di-tert-butylimidazolin-2-ylidene27 (0.50 g,
2.8 mmol) was dissolved in THF (10 mL). 4-Bromobenzyl bromide
(0.70 g, 2.8 mmol) was added resulting in a slightly yellow, turbid
soln. KOt-Bu (0.31 g, 2.8 mmol) was added. After stirring at r.t.
overnight the mixture was filtered through Celite. The solvent was
removed from the slightly yellow filtrate to give 3k (2.32 mmol,
82%) as an off-white solid.
3
1H NMR (360 MHz, benzene-d6): d = 7.42 (d, JHH = 8.5 Hz, 2 H,
IR (ATR): 3085, 2959, 2921, 2860, 2167, 1741, 1596, 1559, 1473,
1381, 1362, 1330, 1211, 1123, 1058, 936, 805, 766, 752, 688 cm–1.
H11), 7.09 (d, 3JHH = 8.5 Hz, 2 H, H10), 6.86 (s, 2 H, H4, H5), 4.18
(s, 2 H, H8), 1.19 (s, 18 H, H7).
1H NMR (600 MHz, THF-d8): d = 7.43 (t, 3JHH = 7.8 Hz, 1 H, H9¢),
13C{1H}-NMR (126 MHz, benzene-d6): d = 160.9 or 155.7 (1 C,
C2), 139.7 (1 C, C9), 131.5 (2 C, C11), 129.1 (2 C, C10), 120.9 (1
C, C12), 115.1 (2 C, C4, C5), 73.1 (2 C, C6), 63.3 (1 C, C8), 27.6
(6 C, C7).
3
3
7.37 (t, JHH = 7.8 Hz, 1 H, H9), 7.32 (d, JHH = 7.8 Hz, 2 H, H8¢,
H10¢), 7.21 (d, 3JHH = 7.8 Hz, 2 H, H8, H10), 6.70 (d, 3JHH = 2.2 Hz,
1 H, H4), 6.68 (d, 3JHH = 2.2 Hz, 1 H, H5), 2.98 (sept, 3JHH = 6.8 Hz,
2 H, H12, H15), 2.88 (sept, 3JHH = 6.9 Hz, 2 H, H12¢, H15¢), 2.38 (s,
1 H, H18), 1.34 (d, 3JHH = 6.8 Hz, 6 H, H13, H16), 1.27–1.20 [m, 18
H, CH(CH3)2].
Synthesis 2011, No. 23, 3784–3795 © Thieme Stuttgart · New York